{"name":"UMN Pharma Inc.","slug":"umn-pharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"ASP7373","genericName":"ASP7373","slug":"asp7373","indication":"Other","status":"phase_2"},{"name":"UMN-0501","genericName":"UMN-0501","slug":"umn-0501","indication":"Other","status":"phase_2"},{"name":"approved egg-derived TIV","genericName":"approved egg-derived TIV","slug":"approved-egg-derived-tiv","indication":"Other","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ASP7374","genericName":"ASP7374","slug":"asp7374","indication":"Psoriasis","status":"phase_3"}]}],"pipeline":[{"name":"ASP7374","genericName":"ASP7374","slug":"asp7374","phase":"phase_3","mechanism":"ASP7374 is a selective inhibitor of TYK2 (tyrosine kinase 2) that suppresses inflammatory signaling pathways involved in immune-mediated diseases.","indications":["Psoriasis","Inflammatory bowel disease"],"catalyst":""},{"name":"ASP7373","genericName":"ASP7373","slug":"asp7373","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"UMN-0501","genericName":"UMN-0501","slug":"umn-0501","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"approved egg-derived TIV","genericName":"approved egg-derived TIV","slug":"approved-egg-derived-tiv","phase":"phase_3","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPRXFtU001TUR1UVlYVjZCdThvVmI0NmxXRjJzTlZDaFJtSEFrRm1ITXg4eTg1b29TQl8zcWJEajF6RUdNQ0VxQndIWjZlWUFiUXA0YzdWSHFURXozVThGZ3FMQ0czd3RmbDVJaEhEQm5XZDZEV293Qi1Yc0lEcXpHNW9sa2ViTmVTVmhLRnJB?oc=5","date":"2024-12-11","type":"pipeline","source":"Frontiers","summary":"Unmet medical needs definition and incentives: stakeholders perspectives on the reform of the EU pharmaceutical legislation - Frontiers","headline":"Unmet medical needs definition and incentives: stakeholders perspectives on the reform of the EU pharmaceutical legislat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxOVGVlSlNUWjJWWkZWTjZuQjA0SkVOMEFWdGFoZW5vcDVVZnRYV1dDRnJlT1BSZG94RHNmMVlXeHp3ZUQ0eVYzN09Ma0xOYlNTVWNNT01NV0lXOElSSE5KRWhDRkVrX1FUOVVPdXNjU2lXVDRpc2NseHA3ZnU4bHRaMUF1d1ZvcVZqX2lTRjc0VHktSWdVWFZhRDU1ZHFjaEQyU2x4UXc4QVRublN1dFpwWkoyUVRQWHVqN1pLcnNXVzFZeFY0Sm56cFhnYmplMXJDUlNXdEdtcEZLcnlHSy1ONTBPc0VqTFhBSWc1azNFTV85MnhqWS1NTW92NEktXzF4NzZvazE1NDBhcWs1NGRlOTM2WXlKaUM3MFJxU1pB?oc=5","date":"2024-06-05","type":"deal","source":"PR Newswire","summary":"TOPIX Pharmaceuticals, Inc. Partners with the University of Minnesota, Center for Drug Design to Develop Groundbreaking ProteXidine Molecule - PR Newswire","headline":"TOPIX Pharmaceuticals, Inc. Partners with the University of Minnesota, Center for Drug Design to Develop Groundbreaking ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE5lMTU1S1BJSUlZMFVONkQ1YmFNcndwUU0xNXNqM1FKVXJxZGdRZ2R1a19vdm0xUjEtWGxIWkFaemhuUW1tYzZxd3E1X21SNmhnVExROFZZQlFLR3RQTjhoVHU0RGV5cTFmamxMU1ZxWl9kN3lJTUJaNQ?oc=5","date":"2024-04-23","type":"pipeline","source":"ArcGIS StoryMaps","summary":"A Glimpse Into Historical Pharma Artifacts - ArcGIS StoryMaps","headline":"A Glimpse Into Historical Pharma Artifacts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQY3lmcF9STVY1MzdiOU9CMGpmUFNHejBiZDVWT1FnUHB0VzQzb2NhYURYbldEc1FIc3g2YXpQTVo3UXhzTTZHT25ITW5oWlctc0FRTDk0TGVtQURCSGNINGRfcjlydm1na2J1NkRzMklBTVZGdVNKcHhtVTc5UDB3aE1xalg0RTlkVjYtb2h3VkJVZ1Rwal9DYmZYRUNBdVRsRmVjXy1oTFA4M1dwbzVtdGpXMlhzdm8?oc=5","date":"2022-11-10","type":"pipeline","source":"University of Minnesota Twin Cities","summary":"U of M College of Pharmacy receives grant to continue diversifying pharmacy workforce - University of Minnesota Twin Cities","headline":"U of M College of Pharmacy receives grant to continue diversifying pharmacy workforce","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPOURPS29reWZYTmN2cXRWRmM4ak9KYXJKZjlQLU92OHhzQ0NRM1dpSVowaF9qVnpkQU9XMmZUS0o4THFiWDhFcmhTY2dUdnlGNlZ2UzliSktJSDJVenY4NXF3aERjNGNDWXFURzIzc1dEWFFjcXBBbS14WUo5YmgxNDdnZDNuaWxQOG9wUw?oc=5","date":"2022-01-26","type":"pipeline","source":"CIDRAP","summary":"Report details where top 100 brand-name Rx drugs are made - CIDRAP","headline":"Report details where top 100 brand-name Rx drugs are made","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPSXFPNnpHOHozNTJIR1JkOWVsS04wNGt6Y0RKMjVVOHNFckF4WEppSXJpenRUdEV2UGl5QzJUam9xNG91bXFLR3YxNF8xTnZMQW53bWxxVVpoNGxiRktBYUgza3gzdkU4OXNNSzB2d0g0dUpXNk41YVZxazV5RVg0YVdsWDVYSlc1NnFGdXdwZw?oc=5","date":"2022-01-14","type":"pipeline","source":"CIDRAP","summary":"Firm tackles US drug shortages during COVID with Wisconsin plant - CIDRAP","headline":"Firm tackles US drug shortages during COVID with Wisconsin plant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5TQjZsMHRfLXBBMkN6Zm9KN3VUUkVXUG01emw1UjRJZC1ydUlTclo0a0Z6Q29IQUZoTlk3M0JudE16RXc0MS02dUlTTEJHaWtNWllYVXQ3eGF0MFhFaVVuSVEwZVh5c1VMRFpiYUZhWWI2T28yTzZBR1NoUVM?oc=5","date":"2021-08-27","type":"regulatory","source":"CIDRAP","summary":"FDA works to mitigate shortage of quit-smoking drug - CIDRAP","headline":"FDA works to mitigate shortage of quit-smoking drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNem5oblJWWm9fbHB3LWRKam1GUzUxZmtFNjhzRHRkTjNubjRmYTU1eFJ3TFlqM2RYR3dpN0VKd2ZKVzBtZXVWYmxIVEFZbk5mVUZVendKMzBKdjdOR1Y3QmRENXpUaTMxSGJDNFRSRnhFYUx2MDBiWlE5a3B2Y19EVlc4VEZIUkc4UEZ5cFR3Wk5sVTBYVzgtZHk4SFlya2ZId2pqQTVLVDQ3RURfY2Yw?oc=5","date":"2019-04-16","type":"pipeline","source":"CIDRAP","summary":"Achaogen bankruptcy raises worry over antibiotic pipeline - CIDRAP","headline":"Achaogen bankruptcy raises worry over antibiotic pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOT0RNN010bWVBaTRSTTNwNFJNNDV4RjQ5V1RWQTZQUUc3Ykl4N1Zfa2RwcGFXNkxLbDk0RHh1UkxUb3hTeVExY1hYeVJrb1RXcnVNTHVkNHhiVHJSNVJJelZrX2dYOFdydndiQVVIemhrNVVzaTh5aDBaMlhpamE4NnRLS1VtOVlCYVlQb3E3NVBEWEtsTnpaYWN0Y3EwcGs?oc=5","date":"2018-07-12","type":"pipeline","source":"CIDRAP","summary":"Novartis drops antibiotic development program - CIDRAP","headline":"Novartis drops antibiotic development program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPRXA3cm80MWJEVVFqcU5RdXZ1UUxlTFhaamtXUkVlZ25YSWt6YWhNNFVSVHpYMjVva3FFZXNING9xN2tQS245SUY1OFJLRW03V19fSllxOXoxUWhSSkZpTjJjNXF0RHZCdHhhRE1weTVHdXR3czM0OXhFSHd5NlQwMDFmOWNodW5DbVhlbW42OGhMVEN0MzBfcG5ab25MeHpib2pTR2E5T3TSAa4BQVVfeXFMTzM1X3JzZXZUQ3pXUk5pZk1DX1BjUkZHQy1NUlRTUlQtbnJPVnZlNkktdjJKejhXYXNFNmwzZjdqUHVPZnZ3aWpDLUcyM04zTk9mbmZfYzB5LU02NnRkZ3dVN1U3MGJlUGJEeVVoWjJFcjhrakFYUmh4SE9maEFMMXdSdWZ1UGdncWRPQ2VTTUN4aVB4SDZYWHVRelBtbjJsZnB2bTJJQkdKSXY5bXZn?oc=5","date":"2018-03-22","type":"pipeline","source":"DNA India","summary":"We can fix unavailability of medicines: Pradyumn Singh - DNA India","headline":"We can fix unavailability of medicines: Pradyumn Singh","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_3":2,"phase_2":2},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}